Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome.
about
New Insight on Epidemiology and Management of Bacterial Bloodstream Infection in Patients with Hematological MalignanciesEuropean guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in LeukemiaImpact of vancomycin resistance on mortality in neutropenic patients with enterococcal bloodstream infection: a retrospective study.Bloodstream infections in neutropenic cancer patients: A practical update.Trends of mortality due to septicemia in Greece: an 8-year analysisSepsis Caused by Extended-Spectrum Beta-Lactamase (ESBL)-Positive K. pneumoniae and E. coli: Comparison of Severity of Sepsis, Delay of Anti-Infective Therapy and ESBL Genotype.Antimicrobial resistance in Asia: current epidemiology and clinical implicationsClinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrosThe current spectrum of infection in cancer patients with chemotherapy related neutropenia.Colonization and infection with extended spectrum beta-lactamase producing Enterobacteriaceae in high-risk patients - Review of the literature from a clinical perspective.Antibiotic resistance in cancer patients.The challenge of antibiotic resistance in haematology patients.Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant enterococci: Three major threats to hematopoietic stem cell transplant recipients.Multidrug-resistant bacteria in hematology patients: emerging threats.The growing threat of multidrug-resistant Gram-negative infections in patients with hematologic malignancies.Efficacy of β-Lactam/β-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia.Prospective Evaluation of Infection Episodes in Cancer Patients in a Tertiary Care Academic Center: Microbiological Features and Risk Factors for Mortality.The emerging problem of bacterial resistance in cancer patients; proceedings of a workshop held by MASCC "Neutropenia, Infection and Myelosuppression" Study Group during the MASCC annual meeting held in Berlin on 27-29 June 2013.Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in cancer patients.A fresh look at polymicrobial bloodstream infection in cancer patients.Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea.Estimating the burden of antimicrobial resistance: a systematic literature review.The relationship between mortality and microbiological parameters in febrile neutropenic patients with hematological malignancies
P2860
Q26799580-6B6F8F30-31F2-4F0F-AEFA-9C1D7DCD8CE9Q34390823-F891AC7D-7F73-4A88-AFF8-CFB4B2EB2D53Q35027260-5E751677-0929-4380-A19A-891667C12463Q36913345-FD9B2EB7-2B98-4AF5-8A2C-9E1956F47967Q36976799-6EED7411-379C-4178-9935-EB1666B5E00DQ37114901-CDAE7024-9258-41A1-8F5F-2394DBC98619Q37192102-13776B4B-CE56-43F7-BCE2-13DA0F59FE03Q37612207-12996947-4DF1-4247-893C-B119D5B10E60Q38131442-3123C635-040D-427F-A391-4DD2E9534E50Q38185120-BC929610-713F-4FE0-A138-F019D8F7FBFCQ38212258-B1B121C0-4443-4416-A112-5A4F675FFD87Q38613929-BBE3A2BB-0D9C-41F5-9418-6E51835A86BBQ38620812-C8A0F533-A31C-4D17-99EE-CAE04DCE6BD3Q38838498-97FBE535-E057-4A1A-9C25-8A51CFAA38CEQ38875315-AD6305B5-798A-4E60-A473-20BD22C35026Q40184233-35D2A11B-ABEC-47F6-BF1F-22A97453C8C6Q40461715-FB4238E8-B42D-4B13-8F6A-91DE9FE1EC37Q40706134-789A94DE-53DB-4291-B35E-04B9ACE4C132Q42199910-33FFAF25-7E22-4170-848A-31127A94D963Q48136538-6B632AEA-8DBE-4E2B-8946-C84F21077F1AQ52728829-61DDE40F-4AD0-408F-AE19-B2854DE87E28Q53689673-7D16BA62-8B62-46CC-BD05-4461BC8EB273Q58770666-3194F33D-7350-4A68-A2AB-1A7D2716C586
P2860
Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Escherichia coli and Klebsiell ...... ion and its impact on outcome.
@en
type
label
Escherichia coli and Klebsiell ...... ion and its impact on outcome.
@en
prefLabel
Escherichia coli and Klebsiell ...... ion and its impact on outcome.
@en
P2093
P2860
P1433
P1476
Escherichia coli and Klebsiell ...... ion and its impact on outcome.
@en
P2093
Byung-Sik Cho
Chang-Ki Min
Dong-Gun Lee
Dong-Wook Kim
Hee-Je Kim
Jae-Cheol Kwon
Jin-Hong Yoo
Jong-Wook Lee
Jung-Hyun Choi
Ki-Seong Eom
P2860
P304
P356
10.1007/S00277-012-1631-Y
P577
2012-11-17T00:00:00Z